Literature DB >> 22836235

Dynamics of endogenous Hsp70 synthesis in the brain of olfactory bulbectomized mice.

Natalia Bobkova1, Irina Guzhova, Boris Margulis, Inna Nesterova, Natalia Medvinskaya, Natalia Medvedinskaya, Alexander Samokhin, Irina Alexandrova, David Garbuz, Evgeny Nudler, Michael Evgen'ev.   

Abstract

Numerous epidemiological studies have established acute brain injury as one of the major risk factors for the Alzheimer's disease (AD). However, the lack of animal models of AD-like degeneration triggered by a defined injury hampered the development of adequate therapies. Here we report that the surgical damage of the olfactory bulbs triggers the development of several pathologies, including amyloid-β accumulation and strong decrease of neuron density in the cortex and hippocampus as well as significant disturbance of spatial memory. Characteristically, these harmful consequences of the olfactory bulbectomy (OBX) have a peculiar dynamics in time with maximal manifestation in periods of 1-1.5 months and 8 months after the surgery and, hence, exhibit biphasic pattern with almost complete recovery period taking place at 5-6 months after the operation. The quantitative determination of endogenous inducible form of Hsp70 in different brain areas of OBX mice demonstrated characteristic fluctuations of Hsp70 levels depending on the time after the operation and age of mice. Interestingly, maximal induction of Hsp70 synthesis in the hippocampus exhibits clear-cut coincidence with the recovery period in OBX animals. The observed correlation enables to suggest curing effect of Hsp70 synthesis at an earlier period of pathology development and establishes it as a possible therapeutic agent for secondary grave consequences of brain injury, such as AD-like degeneration, for which neuroprotective therapy is urgently needed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22836235      PMCID: PMC3508132          DOI: 10.1007/s12192-012-0359-x

Source DB:  PubMed          Journal:  Cell Stress Chaperones        ISSN: 1355-8145            Impact factor:   3.667


  40 in total

1.  Exogenous mammalian extracellular HSP70 reduces endotoxin manifestations at the cellular and organism levels.

Authors:  Elena Rozhkova; Marina Yurinskaya; Olga Zatsepina; David Garbuz; Vadim Karpov; Sergei Surkov; Arkady Murashev; Vladimir Ostrov; Boris Margulis; Mikhail Evgen'ev; Maxim Vinokurov
Journal:  Ann N Y Acad Sci       Date:  2010-06       Impact factor: 5.691

2.  Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice.

Authors:  C J Cummings; Y Sun; P Opal; B Antalffy; R Mestril; H T Orr; W H Dillmann; H Y Zoghbi
Journal:  Hum Mol Genet       Date:  2001-07-01       Impact factor: 6.150

Review 3.  Multimodal monitoring and neurocritical care bioinformatics.

Authors:  J Claude Hemphill; Peter Andrews; Michael De Georgia
Journal:  Nat Rev Neurol       Date:  2011-07-12       Impact factor: 42.937

Review 4.  Traumatic brain injury and amyloid-β pathology: a link to Alzheimer's disease?

Authors:  Victoria E Johnson; William Stewart; Douglas H Smith
Journal:  Nat Rev Neurosci       Date:  2010-05       Impact factor: 34.870

5.  Hsp70 stabilizes lysosomes and reverts Niemann-Pick disease-associated lysosomal pathology.

Authors:  Thomas Kirkegaard; Anke G Roth; Nikolaj H T Petersen; Ajay K Mahalka; Ole Dines Olsen; Irina Moilanen; Alicja Zylicz; Jens Knudsen; Konrad Sandhoff; Christoph Arenz; Paavo K J Kinnunen; Jesper Nylandsted; Marja Jäättelä
Journal:  Nature       Date:  2010-01-28       Impact factor: 49.962

6.  Suppression of Alzheimer's disease-related phenotypes by expression of heat shock protein 70 in mice.

Authors:  Tatsuya Hoshino; Naoya Murao; Takushi Namba; Masaya Takehara; Hiroaki Adachi; Masahisa Katsuno; Gen Sobue; Takahide Matsushima; Toshiharu Suzuki; Tohru Mizushima
Journal:  J Neurosci       Date:  2011-04-06       Impact factor: 6.167

7.  Vaccination with peptide 173-193 of acetylcholine receptor α7-subunit prevents memory loss in olfactory bulbectomized mice.

Authors:  Anna V Kamynina; Olga M Volpina; Natalya I Medvinskaya; Irina Ju Aleksandrova; Tatyana D Volkova; Dmitriy O Koroev; Aleksandr N Samokhin; Inna V Nesterova; Irina V Shelukhina; Elena V Kryukova; Viktor I Tsetlin; Vadim T Ivanov; Natalya V Bobkova
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

8.  Viable mouse gene ablations that robustly alter brain Aβ levels are rare.

Authors:  Jeremy H Toyn; Xu-Alan Lin; Mark W Thompson; Valerie Guss; Jere E Meredith; Sethu Sankaranarayanan; Nestor Barrezueta; John Corradi; Antara Majumdar; Daniel L Small; Melissa Hansard; Thomas Lanthorn; Ryan S Westphal; Charles F Albright
Journal:  BMC Neurosci       Date:  2010-11-05       Impact factor: 3.288

9.  Olfactory dysfunction correlates with amyloid-beta burden in an Alzheimer's disease mouse model.

Authors:  Daniel W Wesson; Efrat Levy; Ralph A Nixon; Donald A Wilson
Journal:  J Neurosci       Date:  2010-01-13       Impact factor: 6.167

Review 10.  Experimental models of traumatic axonal injury.

Authors:  Hong-Cai Wang; Yan-Bin Ma
Journal:  J Clin Neurosci       Date:  2009-12-29       Impact factor: 1.961

View more
  10 in total

1.  Olfactory Deprivation Hastens Alzheimer-Like Pathologies in a Human Tau-Overexpressed Mouse Model via Activation of cdk5.

Authors:  Ke Li; Fang-Fang Liu; Chun-Xue He; He-Zhou Huang; Ao-Ji Xie; Fan Hu; Dan Liu; Jian-Zhi Wang; Ling-Qiang Zhu
Journal:  Mol Neurobiol       Date:  2014-12-03       Impact factor: 5.590

2.  The importance of the cellular stress response in the pathogenesis and treatment of type 2 diabetes.

Authors:  Philip L Hooper; Gabor Balogh; Eric Rivas; Kylie Kavanagh; Laszlo Vigh
Journal:  Cell Stress Chaperones       Date:  2014-02-13       Impact factor: 3.667

3.  Ocimum sanctum Linn. Extract Improves Cognitive Deficits in Olfactory Bulbectomized Mice via the Enhancement of Central Cholinergic Systems and VEGF Expression.

Authors:  Xoan Thi Le; Hien Thu Nguyen; Tai Van Nguyen; Hang Thi Nguyet Pham; Phuong Thi Nguyen; Khoi Minh Nguyen; Ba Van Nguyen; Kinzo Matsumoto
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-30       Impact factor: 2.629

4.  The brain compensatory mechanisms and Alzheimer's disease progression: a new protective strategy.

Authors:  Natalia Bobkova; Vasily Vorobyov
Journal:  Neural Regen Res       Date:  2015-05       Impact factor: 5.135

5.  The Y-Box Binding Protein 1 Suppresses Alzheimer's Disease Progression in Two Animal Models.

Authors:  N V Bobkova; D N Lyabin; N I Medvinskaya; A N Samokhin; P V Nekrasov; I V Nesterova; I Y Aleksandrova; O G Tatarnikova; A G Bobylev; I M Vikhlyantsev; M S Kukharsky; A A Ustyugov; D N Polyakov; I A Eliseeva; D A Kretov; S G Guryanov; L P Ovchinnikov
Journal:  PLoS One       Date:  2015-09-22       Impact factor: 3.240

6.  Immunization Against Specific Fragments of Neurotrophin p75 Receptor Protects Forebrain Cholinergic Neurons in the Olfactory Bulbectomized Mice.

Authors:  Natalia Bobkova; Vasily Vorobyov; Natalia Medvinskaya; Inna Nesterova; Olga Tatarnikova; Pavel Nekrasov; Alexander Samokhin; Alexander Deev; Frank Sengpiel; Dmitry Koroev; Olga Volpina
Journal:  J Alzheimers Dis       Date:  2016-05-06       Impact factor: 4.472

Review 7.  Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities.

Authors:  Chen Hu; Jing Yang; Ziping Qi; Hong Wu; Beilei Wang; Fengming Zou; Husheng Mei; Jing Liu; Wenchao Wang; Qingsong Liu
Journal:  MedComm (2020)       Date:  2022-08-02

Review 8.  Impact of Heat Shock Proteins in Neurodegeneration: Possible Therapeutical Targets.

Authors:  Giangiacomo Beretta; Aida Loshaj Shala
Journal:  Ann Neurosci       Date:  2022-01-31

Review 9.  Heat shock proteins: a history of study in Russia.

Authors:  Mikhail Borisovich Evgen'ev
Journal:  Cell Stress Chaperones       Date:  2021-06-28       Impact factor: 3.667

Review 10.  Role of a Heat Shock Transcription Factor and the Major Heat Shock Protein Hsp70 in Memory Formation and Neuroprotection.

Authors:  Olga G Zatsepina; Michael B Evgen'ev; David G Garbuz
Journal:  Cells       Date:  2021-06-29       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.